These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31320453)

  • 1. Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study.
    Huitema MP; Bakker ALM; Mager JJ; Rensing BJWM; Smits F; Snijder RJ; Grutters JC; Post MC
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31320453
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis.
    Huitema MP; Spee M; Vorselaars VM; Boerman S; Snijder RJ; van Es HW; Reesink HJ; Grutters JC; Post MC
    Eur Respir J; 2016 Feb; 47(2):673-6. PubMed ID: 26493790
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis.
    Handa T; Nagai S; Miki S; Fushimi Y; Ohta K; Mishima M; Izumi T
    Chest; 2006 May; 129(5):1246-52. PubMed ID: 16685015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry.
    Baughman RP; Shlobin OA; Wells AU; Alhamad EH; Culver DA; Barney J; Cordova FC; Carmona EM; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Kouranos V; O'Hare L; Baran JM; Cal JG; Lower EE; Engel PJ; Nathan SD
    Respir Med; 2018 Jun; 139():72-78. PubMed ID: 29858005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors.
    Rapti A; Kouranos V; Gialafos E; Aggeli K; Moyssakis J; Kallianos A; Kostopoulos C; Anagnostopoulou O; Sfikakis PP; Wells AU; Tzelepis GE
    Lung; 2013 Feb; 191(1):61-7. PubMed ID: 23229755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function.
    Maimon N; Salz L; Shershevsky Y; Matveychuk A; Guber A; Shitrit D
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):406-11. PubMed ID: 23407231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry.
    Shlobin OA; Kouranos V; Barnett SD; Alhamad EH; Culver DA; Barney J; Cordova FC; Carmona EM; Scholand MB; Wijsenbeek M; Ganesh S; Lower EE; Engel PJ; Wort J; Price L; Wells AU; Nathan SD; Baughman RP
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32139456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension in sarcoidosis.
    Baughman RP; Engel PJ; Meyer CA; Barrett AB; Lower EE
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Jun; 23(2):108-16. PubMed ID: 17937106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis.
    Nunes H; Humbert M; Capron F; Brauner M; Sitbon O; Battesti JP; Simonneau G; Valeyre D
    Thorax; 2006 Jan; 61(1):68-74. PubMed ID: 16227329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary haemodynamics after single-lung transplantation for end-stage pulmonary parenchymal disease.
    Bjørtuft O; Simonsen S; Geiran OR; Fjeld JG; Skovlund E; Boe J
    Eur Respir J; 1996 Oct; 9(10):2007-11. PubMed ID: 8902458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.
    Benn BS; Lehman Z; Kidd SA; Ho M; Sun S; Ramstein J; Arger NK; Nguyen CP; Su R; Gomez A; Gelfand JM; Koth LL
    Lung; 2017 Oct; 195(5):553-561. PubMed ID: 28707108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endpoints in sarcoidosis: More like IPF or asthma?
    Judson MA
    Respir Med; 2018 May; 138S():S3-S4. PubMed ID: 29174488
    [No Abstract]   [Full Text] [Related]  

  • 13. Non specific pattern of lung function in a respiratory physiology unit: causes and prevalence: results of an observational cross-sectional and longitudinal study.
    Chevalier-Bidaud B; Gillet-Juvin K; Callens E; Chenu R; Graba S; Essalhi M; Delclaux C
    BMC Pulm Med; 2014 Sep; 14():148. PubMed ID: 25233902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled iloprost for sarcoidosis associated pulmonary hypertension.
    Baughman RP; Judson MA; Lower EE; Highland K; Kwon S; Craft N; Engel PJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):110-20. PubMed ID: 20560291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation.
    Baughman RP; Engel PJ; Taylor L; Lower EE
    Chest; 2010 Nov; 138(5):1078-85. PubMed ID: 20348196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary hypertension associated with lung pathology - single or multiple causes?].
    Szturmowicz M
    Pneumonol Alergol Pol; 2013; 81(3):187-91. PubMed ID: 23609424
    [No Abstract]   [Full Text] [Related]  

  • 17. Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment.
    Fisher KA; Serlin DM; Wilson KC; Walter RE; Berman JS; Farber HW
    Chest; 2006 Nov; 130(5):1481-8. PubMed ID: 17099027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed Ventilatory Defects in Pulmonary Sarcoidosis: Prevalence and Clinical Features.
    Kouranos V; Ward S; Kokosi MA; Castillo D; Chua F; Judge EP; Thomas S; Van Tonder F; Devaraj A; Nicholson AG; Maher TM; Renzoni EA; Wells AU
    Chest; 2020 Nov; 158(5):2007-2014. PubMed ID: 32534908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis.
    Keijsers RG; Verzijlbergen EJ; van den Bosch JM; Zanen P; van de Garde EM; Oyen WJ; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):123-9. PubMed ID: 22117503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nifedipine on physiologic shunting and oxygenation in chronic obstructive pulmonary disease.
    Kalra L; Bone MF
    Am J Med; 1993 Apr; 94(4):419-23. PubMed ID: 8475936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.